We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PRTO market cap is 9.49M. The company's latest EPS is USD -3.5565 and P/E is -0.24.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -9.73M | -12.14M | -10.7M | -11.04M | -11.85M |
Net Income | -9.05M | -11.29M | -9.86M | -10.22M | -11.1M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -15.25M | -34.44M | -47.49M | -67.06M | -43.61M |
Net Income | -14.99M | -33.98M | -47.25M | -65.95M | -40.42M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 106.41M | 95.14M | 88.47M | 78.95M | 68.13M |
Total Liabilities | 11.64M | 9.92M | 11.51M | 10.63M | 9.73M |
Total Equity | 94.77M | 85.23M | 76.96M | 68.32M | 58.41M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 6.98M | 203.16M | 172.6M | 113.29M | 78.95M |
Total Liabilities | 583k | 3.91M | 10.68M | 11.21M | 10.63M |
Total Equity | 6.39M | 199.24M | 161.91M | 102.08M | 68.32M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -12.89M | -22.3M | -28.86M | -37.56M | -10.38M |
Investing | 9.86M | 32.21M | 38.59M | 53.11M | 23.1M |
Financing | -64k | -64k | -91k | -91k | -76k |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -15.65M | -23.41M | -34.5M | -26.46M | -37.56M |
Investing | 2.48M | 2.84M | -98.19M | 14.95M | 53.11M |
Financing | N/A | 189.4M | -228k | -90k | -91k |
Market Cap | 9.49M |
Price to Earnings Ratio | -0.24 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.24 |
Price to Book Ratio | 0.14 |
Dividend Yield | - |
Shares Outstanding | 11.37M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.05 (6.41%) |
Company Name | Proteon Therapeutics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://protaratx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions